Status | Study |
Completed |
Study Name: Nitroglycerin Infusion During Cardiac Surgery Condition: Lactic Acidosis Bleeding Date: 2013-07-10 Interventions: Drug: Nitroglycerin infusion Nitroglycerin infusion during rewarming |
Completed |
Study Name: Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast Media Condition: Diabetes Mellitus Lactic Acidosis Date: 2013-06-05 Interventions: Drug: Metformin Incidence of lactic acidosis in diabetic patients receiving contrast media in the presen |
Completed |
Study Name: Lactic Acidosis During and After Seizures Condition: Epilepsy Date: 2013-03-28 |
Active, not recruiting |
Study Name: Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Open Label Condition: Mitochondrial Enzyme Deficiencies Date: 2013-02-15 Interventions: Drug: Dichloroacetate Subjects are given DCA 25mg/kg in a divided dose twice a day. |
Completed |
Study Name: RBC Transfusion in Severe Anemia With Lactic Acidosis Condition: Anemia Date: 2012-04-25 Interventions: Biological: RBC transfusion RBC transfusion of different storage age |
Completed |
Study Name: Effect of Blood Storage Age on the Resolution of Lactic Acidosis in Children With Severe Malarial Anemia at Mulago Hospital Condition: Compare Blood Age for Transfusion Date: 2012-04-17 Interventions: Biological: Blood transfusion The short storage arm; children were transfused with packed red cells of s |
Recruiting |
Study Name: Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery Condition: Heart Failure Acidosis, Lactic Date: 2012-01-30 Interventions: Drug: Vitamin B1-ratiopharm 30 |
Completed |
Study Name: Metformin Treatment, Renal Function and Lactic Acidosis Condition: Type 2 Diabetes Mellitus Date: 2011-05-19 |
Terminated |
Study Name: Lactic Acidosis During Entecavir(ETV)Treatment Condition: Lactic Acidosis Date: 2011-05-11 Interventions: Drug: entecavir, lamivudine entecavir: 0.5mg/day p.o until |
Completed |
Study Name: Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients Condition: Shock, Hemorrhagic Shock, Traumatic Date: 2010-12-15 Interventions: Drug: MP4OX 4.3 g/dL pegylated |